Left Ventricular Noncompaction 2 C1836118
Left Ventricular Noncompaction 2 is a congenital heart disorder where the left ventricle has a spongy appearance due to incomplete development. It can affect heart function and increase risk of blood clots. Management focuses on medications and regular cardiac follow-up.
Key facts at a glance
- ICD-10
- I78.0
- ICD-11
- BA00.0
- Body system
- cardiovascular
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Chest discomfort
Thromboembolic event
Chest discomfort or palpitations
(cardiovascular)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Fatigue
(cardiovascular)Exercise intolerance
(cardiovascular)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
ACE Inhibitor or ARB Therapy
Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers to reduce cardiac afterload, improve ventricular remodeling, and decrease heart failure hospitalizations. Cornerstone of long-term disease management.
Disease management and monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Permanent Pacemaker Implantation
Device therapy for patients with conduction abnormalities or bradyarrhythmias associated with LVNC. Helps maintain appropriate heart rate and improves cardiac output in those with rhythm disturbances.
Additional treatment options
Antiarrhythmic Management
Pharmacological management of atrial and ventricular arrhythmias using appropriate antiarrhythmic agents based on rhythm type and patient characteristics. Often used adjunctively with device therapy.
medicationHeart Transplantation Evaluation
Comprehensive evaluation for advanced heart failure patients who fail optimal medical therapy and device therapy. Represents definitive treatment for end-stage disease with severe systolic dysfunction.
surgicalPsychological Support and Counseling
Mental health support addressing anxiety, depression, and adjustment challenges common in chronic cardiac disease. Includes coping strategies, family counseling, and connection to support networks.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Left Ventricular Noncompaction 2 C1836118?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Left Ventricular Noncompaction 2 C1836118. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy